pemafibrate
Kowa Pharmaceuticals
[]
data from the prominent trial at #aha22 indicate the incidence of cv events was not lower among patients who received pemafibrate than those who received placebo. 
Clinical News for Connected Physicians. Everything you need to enhance your clinical approach to improving patient care.